Fierce Biotech News & Reports

ASCO: Lilly's faith in Kelonia rewarded with ‘nutty’ CAR-T data

Kelonia shared the largest slice of data yet for its in vivo CAR-T, helping to justify the $3.2 billion price tag Lilly recently paid for the biotech.

Darren Incorvaia May 31, 2026 8:00am

Lilly's $1.2B deal for Hanmi GLP-2 drug for short bowel syndrome

Jun 1, 2026 3:52am

Entry Japan with Clarity Execute with Confidence

PATH-Solution

Brought to you by Alfresa Holdings Corporation

Fierce Pharma

Akeso's 34% overall survival win comes with caveats

May 31, 2026 8:00am

ASCO: RevMed confident in RAS leadership as rivals square up

May 31, 2026 8:00am

ASCO: Telix tees up pivotal test for Pluvicto challenger

Jun 1, 2026 4:12pm

More News

At ASCO 2026, a ‘paradigm shift’ for a rare gut cancer looms

Jun 1, 2026 3:55pm

ASCO, Ryght AI team up for breast cancer trial site selection

Jun 1, 2026 2:00pm

Agios signs $165M deal for blood disorder drug that failed study

Jun 1, 2026 9:26am

Rallybio swerves past Candid pothole to land deal with Avenzo

Jun 1, 2026 9:09am

See more stories